ArticleBlood2007

Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production.

James T Snyder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.